Literature DB >> 7713989

The effect of a mesogenic and a lentogenic Newcastle disease virus strain on Burkitt lymphoma Daudi cells.

Y Tzadok-David1, M Metzkin-Eizenberg, Z Zakay-Rones.   

Abstract

The destructive effect of Newcastle disease virus (NDV) strains on Burkitt lymphoma Daudi cells was investigated. Interaction of an active and UV-inactivated mesogenic strain (Roakin), as well as an active attenuated lentogenic strain (B1), grown in the allantoic sac of embryonated eggs, at high multiplicity, caused inhibition in cellular DNA synthesis and arrest in cell multiplication, eventually killing of the cells. The lentogenic strain cultivated in chicken fibroblasts exhibited only a moderate activity. The mechanism of the cytolytic effect is presumably linked to the increase in cell membrane permeability indicated by the elevation in 51Cr release. Thus it appears that the massive adsorption and/or penetration of viral particles, active or UV-inactivated (or possibly a toxic component that resides in the virion), damages the plasma membrane and may be responsible for the killing of the cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7713989     DOI: 10.1007/bf01198099

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  27 in total

1.  Determination of cell viability.

Authors:  J H HANKS; J H WALLACE
Journal:  Proc Soc Exp Biol Med       Date:  1958-05

2.  Selective inhibition of protein synthesis in virus-infected mammalian cells.

Authors:  A Contreras; L Carrasco
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

3.  Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1974-02       Impact factor: 3.616

4.  Enhancement of potassium influx, in baby hamster kidney cells and chicken erythrocytes, during adsorption of parainfluenza 1 (Sendai) virus.

Authors:  P Fuchs; E Giberman
Journal:  FEBS Lett       Date:  1973-04-01       Impact factor: 4.124

5.  Control of protein synthesis in human fibroblasts by intracellular potassium.

Authors:  M L Ledbetter; M Lubin
Journal:  Exp Cell Res       Date:  1977-03-15       Impact factor: 3.905

6.  Modification of membrane permeability induced by animal viruses early in infection.

Authors:  L Carrasco
Journal:  Virology       Date:  1981-09       Impact factor: 3.616

7.  Nature of virally mediated changes in membrane permeability to small molecules.

Authors:  C C Impraim; K A Foster; K J Micklem; C A Pasternak
Journal:  Biochem J       Date:  1980-03-15       Impact factor: 3.857

8.  Modification of membrane permeability during Semliki Forest virus infection.

Authors:  A Muñoz; J L Castrillo; L Carrasco
Journal:  Virology       Date:  1985-10-30       Impact factor: 3.616

9.  Attenuated veterinary virus vaccine for the treatment of cancer.

Authors:  L K Csatary; S Eckhardt; I Bukosza; F Czegledi; C Fenyvesi; P Gergely; B Bodey; C M Csatary
Journal:  Cancer Detect Prev       Date:  1993

10.  Sensitivity of Burkitt lymphoma Daudi cells to inactive influenza virus.

Authors:  Y Shlomi; Z Zakay-Rones
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

View more
  9 in total

1.  Preferential cytotoxic effect of Newcastle disease virus on lymphoma cells.

Authors:  N Bar-Eli; H Giloh; M Schlesinger; Z Zakay-Rones
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 2.  Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions.

Authors:  Dmitriy Zamarin; Peter Palese
Journal:  Future Microbiol       Date:  2012-03       Impact factor: 3.165

3.  Recent advances of oncolytic virus in cancer therapy.

Authors:  Moumita Mondal; Jingao Guo; Ping He; Dongming Zhou
Journal:  Hum Vaccin Immunother       Date:  2020-02-20       Impact factor: 3.452

4.  An overview on the development of newcastle disease virus as an anti-cancer therapy.

Authors:  Abdul Rahman Omar; Aini Ideris; Abdul Manaf Ali; Fauziah Othman; Khatijah Yusoff; Jafri Malin Abdullah; Haryati Shila Mohamad Wali; Madihah Zawawi; Narayani Meyyappan
Journal:  Malays J Med Sci       Date:  2003-01

5.  Genetically engineered Newcastle disease virus for malignant melanoma therapy.

Authors:  D Zamarin; A Vigil; K Kelly; A García-Sastre; Y Fong
Journal:  Gene Ther       Date:  2009-02-26       Impact factor: 5.250

Review 6.  Oncolytic viruses.

Authors:  J Nemunaitis
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.651

7.  Newcastle disease virus mediated apoptosis and migration inhibition of human oral cancer cells: A probable role of β-catenin and matrix metalloproteinase-7.

Authors:  Sudhir Morla; Ajay Kumar; Sachin Kumar
Journal:  Sci Rep       Date:  2019-07-26       Impact factor: 4.379

8.  Newcastle Disease Virus: Potential Therapeutic Application for Human and Canine Lymphoma.

Authors:  Diana Sánchez; Rosana Pelayo; Luis Alberto Medina; Eduardo Vadillo; Rogelio Sánchez; Luis Núñez; Gabriela Cesarman-Maus; Rosa Elena Sarmiento-Silva
Journal:  Viruses       Date:  2015-12-23       Impact factor: 5.048

9.  Oncolysis by paramyxoviruses: preclinical and clinical studies.

Authors:  Olga V Matveeva; Zong S Guo; Vyacheslav M Senin; Anna V Senina; Svetlana A Shabalina; Peter M Chumakov
Journal:  Mol Ther Oncolytics       Date:  2015-10-21       Impact factor: 7.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.